RespiraSense Versus Capnography & Manual Counting

PMD Solutions

Status: Completed

Conditions: Respiratory Rate

Treatments: Device: RespiraSense patient respiratory monitor system

Study type: Observational

Funder types: Industry

Identifiers

NCT03148873

PMD-CS-007

Details and patient eligibility

About

Your respiratory rate is your number of breaths per minute. The standard way for this to be measured is by a nurse looking at you for one minute and manually counting your breaths over this time. They normally do this once every few hours. At times, it can be useful to have your respiratory rate continuously monitored. A device that can do this is a capnograph. For the patient, this involves wearing a tube in their nose and around their ears while trying to minimise their movement and talking so the measurements can be taken.

This research study is looking at a new respiratory rate monitor and comparing how well it works against the current accepted methods.

Patients who are admitted to the Acute Medical Unit will be invited to participate should they meet all eligibility criteria.

Subjects will be monitored for two hours:

(i) For the first hour subjects will wear a capnograph, RespiraSense and have their respiratory rate manually counted by a research nurse. During this time the subject will be asked to keep talking and moving to a minimum.

(ii) For the second hour subjects will wear RespiraSense and have their respiratory rate manually counted by a research nurse. During this time the subject can talk and move as they wish.

Enrollment: 24 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• ≥18 years
• Acute admission to be measured within the first 24 hours of this admission episode
• Are willing to voluntarily sign a statement of informed consent to participate in this investigation

Exclusion criteria

• Allergic to medical grade skin adhesive
• Pregnant women during second and third trimester
• Patients who are determined by the medical team to have fragile skin unsuitable for application of the adhesive of the RespiraSense sensor. Patients under the influence of substance abuse (drug or alcohol) that may interfere with their ability to cooperate and comply with the investigation procedures
• Any disorder, including cognitive dysfunction, which would affect the ability to freely give full informed consent
• Patients whose health is deteriorating and unstable
• Patients with predominant palliative care needs
• Patients with a National Early Warning Score (NEWS) of > 5